To support the relevance of the NRs cluster analysis in identifying novel targetable hits to modulate hepatocyte proliferation, we activated PPARδ pharmacologically using its high-affinity synthetic agonist GW501516, and we showed that PPARδ reduces the proliferative rates of Hepa 1-6 hepatoma cell line. This evidence concerns the gene PPARD and hepatocellular carcinoma.